Dudediligence.

Lakewood-Amedex Biotherapeutics, Inc

LABTNASDAQ · Pharmaceutical Preparations
Write an idea

Price
FilingsNewest: 8-K, Shareholder voteSep 28 →InsidersNo open-market buys or sales.→HoldersMarex 2.2%UBS 0.2%Tower Research Capital LLC (TRC) 0.0%→

From the filings

Figures

Net income
−$4.2Mlast 12 months
Operating cash flow
−$1.9Mlast 12 months
Cash and equivalents
$2.6Mat the last balance sheet
Shares outstanding
2.2M shareson issue
Every year and quarter →